hotspot -WSS

hotspot

author：entertainment 2025-09-28 20:44:28 - browse：481

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： How a billionaire couple greased the skids for Pelosi’s drug pricing bill

focus

WSS

Readers respond to H5N1 and livestock movements, and more

The tragedy of Johnson & Johnson’s Covid vaccine

Copay coupons to count toward deductibles, after Biden court move

Parkinson’s finding may lead to tests and, someday, treatments

AI generated plenty of interest at JPM but not a lot of trust

Prior authorization will have to move faster under new Biden rule

entertainment

hotspot

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

Humana cuts profit projections as Medicare Advantage costs soar

In Memoriam: Notable people who died in 2023

Copay coupons to count toward deductibles, after Biden court move

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Tori Bowie and the unacceptable rates of Black maternal death

Case highlights the risks of experimental stem cell therapy

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Criminal prosecution for violating HIPAA: an emerging threat

leisure time

Case highlights the risks of experimental stem cell therapy

Biotech venture capitalists face new demands from investors

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Wikipedia

leisure time

focus

knowledge